Literature DB >> 10739401

Thrombophilic mutations in Iran.

S Zeinali, F Duca, B Zarbakhsh, L Tagliabue, P M Mannucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10739401

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

1.  Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Hadi Mozafari; Hadi Kharrazi; Mansour Rezaei; Ronald L Nagel
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

2.  Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2010-04-07       Impact factor: 2.316

3.  A Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR) for the Detection of Factor V Leiden and Prothrombin G20210A.

Authors:  Morteza Bagheri; Isa Abdi Rad
Journal:  Maedica (Buchar)       Date:  2011-01

4.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 5.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

6.  Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Ronald L Nagel; Adriana Muniz
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

7.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

8.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

9.  Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss.

Authors:  Majid Teremmahi Ardestani; Hossein Hadi Nodushan; Abbas Aflatoonian; Nasrin Ghasemi; Mohammad Hasan Sheikhha
Journal:  Iran J Reprod Med       Date:  2013-01

10.  Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults.

Authors:  Ehsan Kheradmand; Meraj Pourhossein; Gilda Amini; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2014-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.